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Human neoplastic cells resistant to the antileukemic agent 6-mer- 
captopurine (6-MP) were examined in tissue culture to study the glyco­
lytic activity of resistant cells. The media, with and without 6-MP, 
of three neoplastic cell lines, HeLa, HEp-2, and J-lll was compared 
for glucose and lactate concentrations before and after incubation.
It was found that in the media of HeLa and HEp-2 cells exposed to 6-MP 
glucose disappearance and lactate formation was enhanced. It was also 
found, however, that glucose and lactate concentrations of the media 
of 6-MP resistant HeLa and HEp-2 cells were not altered by the activ­
ity of 6-MP. On the other hand, in the media of J-lll cells both 
sensitive and resistant to 6-MP glucose and lactate concentrations 
were not changed by the activity of 6-MP.
The results indicate that with the development of resistance to 
6-MP, HeLa and HEp-2 cells no longer are stimulated by 6-MP to use ex­
tracellular glucose at an increased rate. It is also known that when 
HeLa and HEp-2 cells develop resistance to 6-MP there is an associated 
inability of both cell types to form the 6-MP ribonucleotide. The in­
terrelationships of these two findings is not known; although it is 
suggested that both cell types develop resistance by a common pathway. 
However, because glycolytic activity in J-lll cells is not stimulated 
by 6-MP it is suggested that resistance may develop by still another 
mechanism.
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Introduction
The most recent mortality statistics available reveal cancer as 
the second leading cause of death in the United States; cardiovascu­
lar diseases rank first .(32) Two thirds of the patients with diag­
nosed malignancies do not survive five years.(33) Surgery and radia­
tion therapy are presently the chief measures of cancer control. With­
in the last 15 years, however, temporary control of certain cancers 
has been achieved by the use of chemical agents; e .g . ,  the treatment 
of acute leukemia with 6-mercaptopurine (6-MP). Although the chemo­
therapeutic approach to cancer has met with moderate success, a major 
stumbling-block plagues advancement. The development of drug resis­
tance1 remains a serious obstacle in the progress of cancer chemother­
apy. Considerable effort has been made at the molecular level to gain 
knowledge regarding the nature of the altered metabolism within the 
drug-sensitive cells with the hope that such knowledge might facilitate 
an understanding of drug resistance.
The purine analog, 6-MP, has been closely examined for its chemo­
therapeutic activity and it has been found that 6-MP is capable of al­
tering many metabolic processes and cell functions within 6-MP-sensi- 
tive cells. Some of the metabolic pathways and cell functions found to 
be sensitive to the activity of 6-MP include: the de novo synthesis of
purines (3- 6,12,13,23); the formation of antibodies (m ,2 7 ,2 8 ) ; the 
synthesis and breakdown of NAD (1 ,2 ,1 7 ) ; and the utilization of glucose. 
(8 ,9 ,10 ,15 ,18 ,19 ,20 ,22 ) These studies have revealed a primary site of
1 The chemical selection and overgrowth of specific drug-resistant mu­
tant cells from large, originally drug sensitive populations of neo­
plastic cells.
2the growth-inhibitory activity of 6-MP. It is now generally considered 
that the de novo synthesis of purines is the pathway most sensitive to 
the inhibitory activity of 6-MP.
Because the de novo synthesis of purines appears to be a sensi­
tive site of the inhibitory activity of 6-MP, the study of 6-MP resis­
tance has focused on this mechanism. It has been reported that 6-MP 
must be converted to 6-MP ribonucleotide in sensitive cells to be an 
inhibitor of the de novo synthesis of purines.(5 ,6 ,12 ,23) The 6-MP 
ribonucleotide has been found to be a potent inhibitor of the first 
irreversible step of purine synthesis (the free base and 6-MP ribonu- 
cleoside were inactive).(21) Studies on resistance have revealed that 
in some tumor cells examined 6-MP resistance is accompanied by the in­
ability of the cells to form the 6-MP ribonucleotide.(5 ,6 ,23) However, 
it has not always been possible to demonstrate the inability of 6-MP- 
resistant cells to form the 6-MP ribonucleotide.(5 ,7 ) Obviously our 
knowledge of the mechanism of resistance still has many gaps.
It was felt, therefore, that the understanding of 6-MP resistance 
might be enhanced by an examination of the glycolytic activity of 6-MP 
resistant cells. The activity of 6-MP on aerobic and anaerobic gly­
colysis (the metabolism of glucose to lactate in the presence and ab­
sence of oxygen) has been studied in a variety of sensitive tumor 
cells. These studies, outlined below, provide a basis from which to 
study the glycolytic activity of 6-MP in resistant cells.
The action of 6-MP on aerobic and anaerobic glycolysis has been 
examined in a number of tumor preparations. In the majority of tumor 
cells examined, 6-MP appears to enhance aerobic glycolysis, but does 
not affect anaerobic glycolysis. Ebina et al. measured anaerobic gly-
colysis in 6-MP treated Yoshida ascites sarcoma, Ehrlich ascites carci­
noma, and rat ascites hepatoma cells .(8) They showed that 6-MP had no 
significant influence on anaerobic glycolysis. The effect of 6-MP on 
anaerobic glycolysis was determined in human acute lymphatic and acute 
myelogenous leukemic cells .(20) It was found that 6-MP did not alter 
anaerobic glycolysis in acute leukemic cells. The action of 6-MP on 
anaerobic glycolysis in cell free systems has also been examined and 
the findings confirm those of Ebina et al. (8) and Laszlo et al.(20) 
Hochstein prepared an actively glycolyzing supernatant fraction from 
S91 mouse melanoma.(16) He showed that 6-MP had no measurable effect 
on anaerobic glycolysis in the supernatant fraction; anaerobic glycoly­
sis in the mitochondrial fraction treated with 6-MP was inhibited 
10-25%.(17)
It appears that 6-MP has no effect on anaerobic glycolysis in 
those tissues examined with one exception: anaerobic glycolysis in
the Crocker mouse sarcoma 180 tumor appears to be uniquely sensitive 
to 6-MP. Mihich et al. reported a 50% inhibition of anaerobic gly­
colysis in Crocker sarcoma 180, carried in 6-MP treated mice.(22)
Fodor et al. have revealed several enzymatic sites of 6-MP inhibition 
of anaerobic glycolysis in sarcoma 180 homogenates.(9,10) Fodor1s 
findings, however, have not been confirmed by reports from other in­
vestigators using different tumor cell preparations. It therefore 
appears that the glycolytic inhibitory activity of 6-MP is peculiar 
to the Crocker mouse sarcoma 180 tumor.
The action of 6-MP on aerobic glycolysis has also been examined. 
Laszlo et al. reported that 6-MP had no effect on aerobic glycolysis 
in acute myelogenous leukemic cells, although aerobic glycolysis was
slightly inhibited in acute lymphatic leukemic cells .(20) Ebina et al. 
showed that in cells from three different types of rat ascites tumors 
examined, 6-MP did not significantly alter aerobic glycolysis.(8)
Ebina1s findings have been recently confirmed in many types of human 
leukemic cells and ascites cells.(18,19) Katchman et al. showed that 
6-MP increased aerobic glycolysis in their tumor cell preparations; 
however, the activation of aerobic glycolysis by 6-MP was found to be 
dependent on the concentration of 6-MP employed.(19) In their experi­
ments in which human leukemic leukocytes and human ascites cells were 
used, 6-MP concentrations of 2-50 yg/106 cells stimulated aerobic gly­
colysis (as measured by lactic acid production), whereas 6-MP concen­
trations above 50 yg/106 cells inhibited aerobic glycolysis.(19)
These findings suggest that at low concentrations, i . e . ,  those con­
centrations which may be achieved under normal physiological condi­
tions, 6-MP stimulates aerobic glycolysis.
To our knowledge alterations of glucose utilization have not been 
examined as a possible cause of development of 6-MP resistance. In 
view of the evidence cited, it was felt that an examination of the 
glycolytic activity of resistant cells might contribute more knowledge 
to the understanding of 6-MP resistance. In the following study, it 
was our purpose to evaluate the relative effects of 6-MP on glucose 
uptake and lactate formation by 6-MP-resistant human cancer cells grown 
in cell culture.
Materials and Methods
Human tumor cells cultivated in tissue culture offer the advantage 
of relative uniformity, controlled growth conditions, and suspensions 
which are especially suitable for metabolic studies. Of the three ser­
ially propagated human cell lines used in the following experiments, 
one was derived from cervical epithelioid carcinoma (HeLa) (11 ), one 
from laryngeal epidermoid carcinoma (HEp-2) (31) and one from acute 
monocytic leukemia (J-lll) (25).
The initial culture of HeLa cells was obtained from Dr. T. T.
Puck. HEp-2 and J-lll cells were purchased from Baltimore Biological 
Laboratories, Baltimore, Maryland. All cell lines and sublines were 
grown attached to soft glass 60 mm Petri dishes, unless otherwise 
stated. The basic medium used in all cultures was composed of 42.5% 
synthetic nutrient (N-16) (26), 42.5% balanced salt solution (Saline 
F) (26) and 15% calf serum. The drug medium was identical to the 
basic medium with the addition of 6-MP. Media were changed every 
three days and all cell lines and sublines were subcultured every six 
days.
Incubation was carried out at 37° in a tight box continuously 
flushed with a water-saturated mixture of 5% CO2 in air. The humidity 
of the box was kept at 90%. The culture media were maintained at pH 
7 .3 . Modal chromosomal range for each cell line was: HeLa 58-86,
HEp-2 63-81 and J-lll 149-188. A count of the per cent polynucleated 
cells was determined and it was found that the cell lines contained 
10-15% and the sublines 15-20% polynucleates.
Resistant sublines of HeLa cells were developed to: 1 .0 , 1.5 and
2.0 yg/ml of 6-MP, respectively. HEp-2 and J-lll cell sublines were 
made resistant to 1.0 Mg/ml. The 6-MP resistant cells were produced by 
seeding Petri dishes with 2 x 10^ cells suspended in drug medium. The 
media were changed twice weekly and the non-attached cells were drawn 
off. Those cells that remained viable after four months continuous ex­
posure to 6-MP were considered drug-resistant.
The cell samples were prepared in the following manner: H to 5
large 60 mm glass Petri dishes were each seeded with 2 x 105 cells sus­
pended in 3 ml of the desired medium and allowed to incubate 3 days.
The cells were then detached from the glass by incubation for 5 minutes 
in 0.01% sodium ethylenediaminetetraacetate and 0.025% trypsin solution. 
The cells from all of the glass dishes were combined into a single tube 
and centrifuged 5 minutes at 250 x G. The packed cells were then: 
washed with a balanced salt solution (Saline F ); resuspended in the de­
sired medium, and counted in a Coulter Counter using a 100 p aperture 
with threshold voltage and aperture current adjusted to count only 
those particles larger than 28 y in diameter. The final cell samples 
were drawn from this inoculum.
To 35 mm plastic culture dishes were added 2 x 106 cells suspended 
in 1 ml of medium. The cell suspension media, devoid of cells, were 
prepared in a similar manner to determine initial concentrations of glu­
cose and lactic acid. All samples were then incubated 4 hours, at which 
time the media were immediately withdrawn and centrifuged (10 minutes at 
2000 x G) under refrigeration to remove unattached cells. Approximately 
5% of the original inoculum did not attach to the plastic culture dishes. 
All media were then analyzed quantitatively for glucose and lactic acid.
The analyses for glucose were performed using the method described
by O’Brien and Ibbott.(24) In this method glucose is specifically es­
timated by using the anzyme glucose oxidase. This enzyme reacts with 
its substrate D-glucose, to give D-gluconic acid and hydrogen peroxide. 
The reaction of hydrogen peroxide with a receptor, O-tolidine, is cat­
alyzed by peroxidase to give a blue color bearing a linear relation­
ship to the concentration of glucose present. The optical density of
the chromatic solution is read in the Beckman DU spectrophotometer at 
625 my.
Lactic acid was assayed using a commercial preparation of lactate 
dehydrogenase (Calbiochem, In c .). Known concentrations of calcium-L- 
lactate (1 and 5 y moles lactate/ml) were compared routinely with each 
sample. In the presence of excess NAD, lactate is converted to pyru­
vate, which is trapped as the hydrazone, with NAD being stoichiometri- 
cally reduced to NADH. The optical density of the NADH is read at 
3*+0 my in the Beckman DU spectrophotometer*
Results
Effect of various 6-MP concentrations on glucose disappearance from 
the culture medium of drug-sensitive and drug-resistant HeLa cells.
In these experiments the influence of various concentrations of 
6-MP on glucose disappearance was examined. It was found (Table I) 
that the amount of glucose which disappeared from the medium of drug- 
sensitive HeLa cells was independent of the 6-MP concentrations (1 .0 , 
1 .5 , 2.0 yg/ml) added to the medium. The amount of glucose which dis­
appeared from the medium of drug-sensitive cells exposed to 6-MP was 
twice as great as the quantity of glucose disappearing from the medi­
um of untreated, drug-sensitive cells. When both sensitive and re­
sistant cells were exposed to identical concentrations of 6-MP, the 
medium of the resistant cells contained one half the amount of glu­
cose found in the medium of the sensitive cells. Although the three 
cell sublines were resistant to three different concentrations of 
6-MP, they showed no differences in glucose disappearance. The media 
of resistant and untreated sensitive HeLa cells displayed comparable 
glucose concentrations after incubation.
Effect of 6-MP on glucose disappearance and lactate formation in the 
media of HeLa, HEp-2, and J-lll cells sensitive or resistant to 6-MP.
The three cell lines were compared as to their aerobic glycolytic 
activity (as measured by the media lactate concentration) before and 
after treatment with 1.0 jig/ml of 6-MP. The data in Table II reveal 
that lactate concentrations were greater in the media of 6-MP treated 
sensitive HeLa and HEp-2 cells than in the media of the untreated 
cells. Glucose disappearance was also enhanced when sensitive HeLa
and HEp-2 cells were treated with 6-MP. Glucose disappearance and lac­
tate formation were quantitatively unaffected in the media of 6-MP 
treated and untreated sensitive J-lll cells.
The three resistant cell sublines were compared to their corre­
sponding sensitive cell lines for glycolytic activity in the presence 
of 6-MP (Table I I I ) .  It was found that the media of resistant HeLa 
and HEp-2 cells contained less lactate than the media of the 6-MP 
treated, sensitive cells. The media of resistant HeLa and HEp-2 
cells also exhibited less glucose disappearance than the treated, sen­
sitive cells media. The level of lactate in the media of resistant 
HeLa and HEp-2 cells was comparable to the lactate concentration in 
the media of the untreated sensitive cells. The media of resistant 
and sensitive 6-MP treated and untreated J-lll cells were found to 
contain equivalent concentrations of lactate. All resistant cell sub­
lines were indistinguishable from their corresponding untreated cell 
lines as measured by glucose disappearance and lactate formation in 
the incubation media.
The quantitative levels of aerobic glycolysis in the three un­
treated cell lines were found to be in the following descending order: 
J-lll> HEp-2> HeLa. The development of resistance to 6-MP in the cell 
sublines did not alter the order of glycolytic activity seen in the 
cell lines. However, the glycolytic order of activity of the 6-MP 
treated sensitive cell lines was: J-lll> HeLa> HEp-2.
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Table I
Each culture dish was inoculated with 2 x 106 cells sus­
pended in 1 ml of basic or drug medium.
Glucose disappearance is the difference between the glu­
cose concentration at time zero and the glucose concentration 
in the dish after 4 hours of incubation. Each figure repre­
sents an average of the indicated number of determinations. 
Glucose disappearance values were compared for significance 
using the Student "t " Test. All values were considered sig­
nificant at P = .02.
Table I
Glucose disappearance from the culture media of HeLa cells 
sensitive and resistant to various concentrations of 6-MP.
6-MP 
(micrograms/ml)
Glucose Disappearance (micromoles/ml) 
Sensitive Resistant
ps’c
0 1.32 ± .14+
(9)§
1.0 3.16 * .16 1.64 ± .36 .001
(10) (10)
1.5 3.25 * .13 1.41 ± .27 .001
(12) (10)
2.0 3.15 * .14 1.62 * .22 .001
(9) (9)
* Probability (Student "t "  Test)
t Standard Deviation. S.D. ~\j' 
§ Number of determinations.
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Table II
Each culture dish was inoculated with 2 x 106 cells sus­
pended in 1 ml of basic or drug medium.
Glucose disappearance is the difference between the glu­
cose concentration at time zero and the glucose concentration 
in the dish after 4 hours of incubation. Lactate formed is 
the net increase in lactic acid found in the media after incu 
bation. All figures represent averages of the indicated num­
ber of determinations. All values were analyzed for signifi­
cance using the Student "t" Test and were considered signifi­
cant at P = .02.
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ITable III
Each culture dish was inoculated with 2 x 106 cells sus­
pended in 1 ml of basic or drug medium.
Glucose disappearance is the difference between the glu­
cose concentration at time zero and the glucose concentration 
in the dish after 4 hours of incubation. Lactate formed is 
the net increase in lactic acid found in the media after incu­
bation. All figures represent averages of the indicated num­
ber of determinations. All values were analyzed for signifi­
cance using the Student "t " Test and were considered signifi­
cant at P = .02.
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Discussion
The glucose, which disappeared from the cell culture media after 
incubation, was assumed to be taken up by the cells. It is assumed 
that the increased amount of glucose which disappeared after sensitive 
HeLa and HEp-2 cells were exposed to 6-MP was the result of the activ­
ity of the drug on the ability of the cells to increase the uptake of 
glucose. The increased amounts of lactate which appeared in the cell 
suspension media probably reflect the metabolism, by the cells, of the 
extracellular glucose or the breakdown of intracellular glycogen. In 
these experiments there is no way to distinguish which of these two 
sources contributed to the observed rise in lactate concentration.
The glycolytic activity of 6-MP in sensitive cells.
In my experiments it was found that of the three cell lines ex­
amined, only two (HeLa and HEp-2) were sensitive to the stimulation 
of glucose disappearance from their media by the activity of 6-MP. In 
one cell line, HeLa, the amount of glucose which disappeared from the 
media was independent of the concentration of 6-MP employed. The 
media of J-lll cells, on the other hand, was not depleted of glucose 
upon the addition of 6-MP. This latter finding does not agree with 
the observations of Katchman et al.(18) They reported that in the 
media of some 30 separate kinds of human cancer cells examined, 6-MP 
enhanced glucose disappearance.(18) J-lll cells therefore appear to 
be unique with respect to their inability to enhance the disappear­
ance of glucose from their incubation media treated with 6-MP.
Also observed in my experiments was an increase in lactate
formation in the media of HeLa and HEp-2 cells treated with 6-MP. This 
finding suggests that not only does 6-MP stimulate glucose disappear­
ance from the media, but it also enhances the aerobic production of 
lactic acid. These observations would seem to confirm similar find­
ings of others.(19) Katchman et a l . , early investigations did not re­
veal a significant increase in lactate production associated with in­
creased glucose disappearance;(18) however, later work demonstrated 
that lactate was increased by the activity of 6-MP.(19)
Katchman et al. have offered two mechanisms by which they ex­
plain the increased glycolytic activity brought about by addition of 
6-MP, i .e . ,  the enhancement of glucose disappearance and lactate 
formation by the action of 6-MP.(18,19) In their first publication 
they suggested that 6-MP stimulated the hexokinase reaction, hence 
the transport of glucose into the cell.(18) However, the work of 
Hochstein does not support this thesis.(15) Hochstein found that 
6-MP has no effect on the hexokinase activity of the supernatant 
fraction of homogenized S91 mouse melanoma; indeed, hexokinase ac­
tivity associated with the mitochondrial fraction was partially in­
hibited. (15)
In the most recent work of Katchman et a l . , the authors suggest 
that 6-MP may inhibit the Pasteur effect and thus allow aerobic gly­
colysis to proceed at an accelerated rate.(19) This proposal appears 
realistic in the light of recent evidence. Sulphydryl containing 
compounds, other than 6-MP, which have been shown to inhibit the Pas­
teur effect include: glutathione and cysteine.(30) A true Pasteur
effect inhibitor has been defined as an agent which stimulates lac­
15
tate formation without inhibiting respiration,(29)
There is some evidence to suggest that 6-MP does not effect res­
piration at concentrations which enhance lactate formation, indicat­
ing 6-MP may indeed be acting as a Pasteur effect inhibitor.(8,19)
Other explanations for the glycolytic activity of 6-MP might in­
clude : 1) 6-MP may enhance respiration (oxygen uptake), hence the
utilization of glucose, however, the evidence indicates that 6-MP 
has no effect on oxygen uptake;(8,19) 2) 6-MP may increase the lev­
els of nicotinamide adenine dinucleotide (NAD) which, if present in 
rate limiting amounts, would stimulate glycolysis. Kaplan showed 
that the level of NAD is increased in mouse liver 20 hours after 6-MP 
administration.(17) My experiments were run only 4 hours; thus it is 
unlikely that NAD reached a level at which glycolysis was stimulated.
The principle result of the activity of 6-MP on sensitive cells 
is the inhibition of cell growth. Yet, my experiments and those of 
Katchman et al. have suggested that 6-MP may enhance glucose uptake 
and lactate formation, processes more compatible with viability than 
with growth-inhibition.(18,19) Therefore, one is tempted to speculate 
that the observed increase in glucose disappearance and lactate forma­
tion is the result of the cells' necessity to use glucose rather than 
the direct activity of 6-MP to stimulate glycolysis. Such a situation 
might arise if 6-MP inhibited the use or transport of nutrients, other 
than glucose. Under these conditions the cell could be required to 
compensate for the nutritional deficit and it might do so by enhancing 
the utilization of the readily available glucose. In this way 6-MP 
would appear to stimulate glycolytic activity, when in fact this drug
may only inhibit the cells’ use of other vital non—carbohydrate nutri­
ents. These proposals are more in keeping with the drug's principle 
activity, i . e . ,  growth inhibition.
The glycolytic activity of 6-MP resistant cells.
Three HeLa cell sublines made resistant to 3 different concentra­
tions of 6-MP were examined for their glycolytic activity. It was 
found that the stimulation of glucose disappearance by 6-MP, observed 
in the media of sensitive cells, did not occur in the media of 6-MP 
resistant cells. No significant differences in glucose disappearance 
were noted between the three cell sublines media. The media of one 
HeLa cell subline, resistant to 1.0 yg/ml 6-MP, was examined for the 
appearance of lactic acid (Table I I I ) .  The data reveal that 6-MP 
does not enhance lactic acid formation in the media of HeLa or Hep-2 
cells resistant to 1.0 yg/ml 6-MP. No significant alterations of 
glucose disappearance and lactate formation were observed in the me­
dia of J-lll cells resistant to 1.0 Mg/ml 6-MP. Resistant HeLa,
HEp-2, and J-lll cells resemble their untreated drug-sensitive cell 
counterparts in their glycolytic activity, in that namely the concen­
tration of glucose and lactate in the media of each 6-MP resistant 
cell subline was in the same quantitative amounts as that found in 
the media of the corresponding drug-sensitive cell line. These ex­
periments suggest that when HeLa and HEp-2 cells become resistant to 
6-MP, they no longer are sensitive to glycolytic stimulation by 6-MP.
Brockman et al. have shown that the growth of HEp-2 cells is 
completely inhibited at 6-MP concentrations of 1.0 pg/ml.(6) An 
HEp-2 cell subline was developed resistant to 1.0 jjg/ml 6-MP and was
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found to grow in the presence of concentrations of 6-MP as high as 
320 jig/ml.(6) These workers found that associated with 6-MP resis­
tance by HEp-2 cells, the resistant cells lost their ability to form 
the 6-MP ribonucleotide. Indirect evidence suggests the action of 
6-MP in 6-MP sensitive and resistant HeLa cells is identical to that 
described in HEp-2 cells.(12,13) The HEp-2 cells used in our exper­
iments were sensitive to the growth-inhibitory effect of 6-MP at 
concentrations of 1.0 yg/ml. HEp-2 cells resistant to 6-MP were de­
veloped in a manner similar to the method described by Brockman et al. 
(6) Therefore, it is probable that the HEp-2 cell line and 6-MP re­
sistant subline used in our experiments were demonstrating the same 
properties as those described in HEp-2 cells used by Brockman et al. 
(6)
My studies indicate that associated with 6-MP resistance in HeLa 
and HEp-2 cells, stimulation of glucose disappearance and lactate 
formation by the action of 6-MP is lost. The close parallelism be­
tween my cell preparations and those of Brockman et al. allows the 
suggestion that with 6-MP resistant HEp-2 and HeLa cells there may 
be a relationship between the resistant cells' inability to form the 
6-MP ribonucleotide and their inability to respond to glycolytic 
stimulation by 6-MP. The relationship of these two observations 
could be made clearer if it were known which form of 6-MP ( i .e . ,  the 
free base or 6-MP ribonucleotide) was acting to enhance glucose dis­
appearance and lactate production in the media of the drug-sensitive 
cell. Nevertheless, it is suggested that both HeLa and HEp-2 cells 
develop resistance by a common pathway and that as a result of re­
sistance both cell types lose their ability to increase glycolytic ac­
tivity after addition of 6-MP.
In my experiments, the media of drug-sensitive acute leukemic 
J-lll cells does not show changes in glucose or lactate concentra­
tions upon the addition of 6-MP. Furthermore, the media of J-lll 
cells does not show concentration differences in glucose or lactate 
concomitant with the development of 6-MP resistance. These findings 
suggest that the mechanism of action of 6-MP in J-lll cells may not 
be the same as that observed in HeLa and HEp-2 cells. Likewise, 6-MP 
resistance in J-lll cells may develop by mechanisms different from 
those described in HeLa and HEp-2 cells. More important, however, is 
the suggestion that 6-MP resistance in J-lll cells may develop by 
mechanisms different from those described in HeLa and HEp-2 cells.
Summary
HeLa cells were exposed to three concentrations (1 .0 , 1 .5 , 2.0 
yg/ml) of 6-MP and it was found that 6-MP stimulated the disappearance 
of glucose from the incubation medium. No relationship was found be­
tween the amount of glucose which disappeared and the concentration 
of 6-MP employed. The media of three 6-MP resistant HeLa cell sub­
lines (each resistant to a different concentration of 6-MP) were 
shown to be refractory to changes in glucose concentrations in the 
presence of 6-MP.
Glucose disappearance and lactate formation in the media of 
HeLa, HEp-2, and J-lll cells were compared in 6-MP-treated and un­
treated drug-sensitive cell lines. All cell lines and resistant sub­
lines were exposed to 1.0 pg/ml 6-MP. Both glucose disappearance 
and lactate production were stimulated in the media of 6-MP-treated 
HeLa and HEp-2 cells. The media of J-lll cells exposed to 6-MP 
showed no increase in glucose disappearance or lactate formation.
The data indicate that about one half of the glucose disappearing 
from the medium by the activity of 6-MP could be accounted for as 
lactate. It was postulated that the increased production of lactate 
was due to 6-MP acting as an inhibitor of the Pasteur effect within 
the cell.
Sublines of HeLa, HEp-2, and J-lll cells resistant to 6-MP were 
found to be refractory to glycolytic stimulation by 6-MP as measured 
by glucose disappearance and lactate formation in the media. These 
findings suggest that with the development of resistance to 6-MP,
there is a decreased sensitivity to the glycolytic stimulatory activ­
ity of 6-MP. It is suggested that the loss of pyrophosphorylase ac­
tivity by 6-MP resistant HeLa and HEp-2 cells, as demonstrated by 
others, may be related to the decreased capacity of resistant cells 
to respond to the glycolytic stimulation of 6-MP.(5 ,6 ) However, it 
appears that resistance in HeLa and HEp-2 cells develops by a common 
pathway. With sensitive acute leukemic J-lll cells, the media of 
which showed no alterations of glucose or lactate concentration by 
6-MP, it was suggested that resistance may develop by still another 
mechanism.
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